BioXcel Therapeutics
BTAI
BTAI
34 hedge funds and large institutions have $1.19M invested in BioXcel Therapeutics in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
8
Closed
5
Calls
$15K
Puts
$4K
Net Calls
+$11K
Net Calls Change
-$2K
Top Buyers
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
-$112K |
2 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$100K |
3 |
Goldman Sachs
New York
|
-$50.3K |
4 |
VF
Virtu Financial
New York
|
-$22K |
5 |
BlackRock
New York
|
-$9.89K |